SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-013611
Filing Date
2022-05-10
Accepted
2022-05-10 16:30:55
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20220331.htm   iXBRL 10-Q 1481057
2 EX-10.1 lyel-20220331x10qxexx101.htm EX-10.1 20568
3 EX-31.1 lyel-20220331x10qxexx311.htm EX-31.1 9607
4 EX-31.2 lyel-20220331x10qxexx312.htm EX-31.2 9579
5 EX-32.1 lyel-20220331x10qxexx321.htm EX-32.1 4991
6 EX-32.2 lyel-20220331x10qxexx322.htm EX-32.2 4944
12 lyel-20220331_g1.jpg GRAPHIC 614118
  Complete submission text file 0001628280-22-013611.txt   8226412

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20220331.xsd EX-101.SCH 50729
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20220331_cal.xml EX-101.CAL 62807
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20220331_def.xml EX-101.DEF 244641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20220331_lab.xml EX-101.LAB 625798
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20220331_pre.xml EX-101.PRE 406019
61 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20220331_htm.xml XML 1062468
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 22910202
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences